Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187798 · ClinicalTrials.gov registry record · NA
Impact of Genetics on Metformin Pharmacokinetics
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00187798 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 24 participants.
The verdict
NCT00187798, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Specific Aims: To compare metformin pharmacokinetics in monozygotic and dizygotic twin pairs. Comparing renal clearance of metformin in monozygotic and dizygotic twins will allow us to better understand the influence of heredity on variation in renal elimination. Furthermore, genotyping renal transporter genes in monozygotic and dizygotic twin pairs with significant differences in renal clearance of metformin may give us insight into the genes responsible for this variability.
Interventions
- DRUG Metformin HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2001-08 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187798
The ClinicalTrials.gov registry entry for NCT00187798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin HCl is the first listed.
NCT00187798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187798 about?
NCT00187798 is a clinical study titled "Impact of Genetics on Metformin Pharmacokinetics". Specific Aims: To compare metformin pharmacokinetics in monozygotic and dizygotic twin pairs. Comparing renal clearance of metformin in monozygotic and dizygotic twins will allow us to better understand the influence of heredity on variation in renal elimination. Furthermore, genotyping renal transp...
What is the current status of trial NCT00187798?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2001-08. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00187798?
The interventions under investigation include: Metformin HCl (DRUG).
Who is sponsoring clinical trial NCT00187798?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.